确保公共卫生系统血浆衍生物供应的承诺与管控。II：国家供应途径调查
Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways.
作者信息
von Bonsdorff Leni, Farrugia Albert, Candura Fabio, O'Leary Peter, Vesga Miguel A, De Angelis Vincenzo
机构信息
International Plasma and Fractionation Association, Amsterdam, The Netherlands.
Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Western Australia, Australia.
出版信息
Vox Sang. 2025 Feb;120(2):124-131. doi: 10.1111/vox.13759. Epub 2024 Oct 30.
Abstract
BACKGROUND AND OBJECTIVES
Pressures on the supply of plasma-derived medicinal products (PDMPs) have led to the efforts to increase the level of plasma collected by public health authorities.
MATERIALS AND METHODS
Public blood collectors were assessed regarding their routes towards domestically sourced plasma and PDMPs.
RESULTS
The collectors' operations were specified and analysed. Models were classified according to the type of plasma collection system and contract fractionation arrangements.
CONCLUSION
Commitment and control to a public plasma collection system are the key features that need to underpin plasma collection.
摘要
背景与目标
血浆衍生药物产品（PDMPs）供应面临的压力促使公共卫生当局努力提高血浆采集量。
材料与方法
对公共采血机构获取国内血浆和PDMPs的途径进行了评估。
结果
明确并分析了采血机构的运作情况。根据血浆采集系统类型和合同分馏安排对模式进行了分类。
结论
对公共血浆采集系统的投入和管控是血浆采集的关键支撑要素。
相似文献
1
Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways.确保公共卫生系统血浆衍生物供应的承诺与管控。II：国家供应途径调查
Vox Sang. 2025 Feb;120(2):124-131. doi: 10.1111/vox.13759. Epub 2024 Oct 30.
2
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape.确保公共卫生系统血浆衍生物供应的承诺与管控。I：全球形势简要回顾。
Vox Sang. 2025 Feb;120(2):114-123. doi: 10.1111/vox.13758. Epub 2024 Oct 30.
3
Generating pathways to domestically sourced plasma-derived medicinal products: Report from a workshop by the International Plasma and Fractionation Association and the Working Party on Global Blood Safety of the International Society of Blood Transfusion.生成国内来源的血浆衍生药物产品的途径：国际血浆和分离协会与国际输血协会全球血液安全工作组研讨会的报告。
Vox Sang. 2024 Sep;119(9):1012-1020. doi: 10.1111/vox.13698. Epub 2024 Jun 26.
4
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy.血浆衍生药品短缺：接下来会怎样？意大利关于其原因及应对政策的叙述性文献综述
Front Pharmacol. 2024 May 6;15:1375891. doi: 10.3389/fphar.2024.1375891. eCollection 2024.
5
Global immunoglobulin supply: steaming towards the iceberg?全球免疫球蛋白供应：驶向冰山？
Curr Opin Allergy Clin Immunol. 2020 Dec;20(6):557-564. doi: 10.1097/ACI.0000000000000696.
6
[Report on notifications pursuant to Section 21 German Transfusion Act for 2005 and 2006].[关于2005年和2006年依据德国输血法第21条的通报报告]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Mar;51(3):353-72. doi: 10.1007/s00103-008-0546-1.
7
The dynamics of contract plasma fractionation.收缩期血浆分离的动力学
Biologicals. 2017 Mar;46:159-167. doi: 10.1016/j.biologicals.2017.02.007. Epub 2017 Feb 21.
8
Challenges associated with access to plasma-derived medicinal products in low middle-income and low-income countries.中低收入和低收入国家获得血浆衍生药物产品所面临的挑战。
Vox Sang. 2024 Feb;119(2):166-170. doi: 10.1111/vox.13555. Epub 2023 Dec 5.
9
The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.墨西哥城有偿血浆捐献者中艾滋病毒传播的流行病学情况，墨西哥
AIDS. 1989 Oct;3(10):631-3. doi: 10.1097/00002030-198910000-00002.
10
The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.意大利实现免疫球蛋白国产化的重要性日益增加。这是一种国家的必然需求。
Blood Transfus. 2019 Nov;17(6):449-458. doi: 10.2450/2019.0265-19. Epub 2019 Dec 11.
引用本文的文献
1
[Strategic independence: a value model for improving access to plasma-derived medicines in Latin AmericaIndependência estratégica: modelo de valor para melhorar o acesso a hemoderivados na América Latina].[战略独立性：改善拉丁美洲血浆衍生药物可及性的价值模型 战略独立性：改善拉丁美洲血液制品可及性的价值模型]
Rev Panam Salud Publica. 2025 May 12;49:e49. doi: 10.26633/RPSP.2025.49. eCollection 2025.
本文引用的文献
1
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape.确保公共卫生系统血浆衍生物供应的承诺与管控。I：全球形势简要回顾。
Vox Sang. 2025 Feb;120(2):114-123. doi: 10.1111/vox.13758. Epub 2024 Oct 30.
2
Blood Donor Incentives across 63 Countries: The BEST Collaborative Study.63个国家的献血者激励措施：BEST合作研究
Transfus Med Rev. 2024 Apr;38(2):150809. doi: 10.1016/j.tmrv.2023.150809. Epub 2023 Dec 16.
3
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation.基于离散事件模拟的英国自体嵌合抗原受体 T 细胞疗法集中式与分散式供应链比较
Cytotherapy. 2021 May;23(5):433-451. doi: 10.1016/j.jcyt.2020.08.007. Epub 2021 Mar 2.
4
Trends in Plasma Toll Fractionation for Self Sufficiency of Plasma-Derived Medicinal Products in Italy.意大利血浆衍生药品自给自足的血浆收费趋势。
Transfus Med Hemother. 2019 Aug;46(4):232-238. doi: 10.1159/000496750. Epub 2019 Feb 5.
5
Plasma is a strategic resource.血浆是一种战略资源。
Transfusion. 2016 Dec;56(12):3133-3137. doi: 10.1111/trf.13913. Epub 2016 Nov 12.
6
Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.血浆采集、合同分馏及血浆衍生药品生产公共系统的可持续性。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s138-47. doi: 10.2450/2013.020s.
7
Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?国家血浆来源的血浆衍生药品自给自足情况：程度如何？
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s132-7. doi: 10.2450/2013.019s.
8
Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations.不同来源血浆组分分离用池的特定蛋白质含量：献血频率的影响。
Vox Sang. 2010 Oct;99(3):220-31. doi: 10.1111/j.1423-0410.2010.01345.x.
Zotero 插件